netFormulary
 Report : A-Z HCD items in Formulary 06/10/2024 00:29:13
[Back]
 
Section Status CCG Name
13.05.03 Formulary CCG Abrocitinib Cibinqo ®
09.01.04 Formulary CCG Avatrombopag Doptelet®
10.01.03 Formulary CCG Baricitinib Olumiant®
13.05.03 Formulary CCG Brodalumab Kyntheum®
11.08.02 Formulary CCG Brolucizumab  Beovu®
10.01.03 Formulary CCG Certolizumab Pegol Cimzia®
06.01.02.03 Formulary CCG Dapagliflozin Forxiga®
13.05.03 Formulary CCG Deucravacitinib SOTYKTU
11.04.01 Formulary CCG Dexamethasone intravitreal implant Ozurdex®
04.07.04.02 Formulary CCG Eptinezumab Vyepti®
04.07.04.02 Formulary CCG Erenumab Aimovig®
06.01.02.03 Formulary CCG Ertugliflozin  Steglatro®
10.01.03 Formulary CCG Filgotinib  Jyseleca®
09.01.04 Formulary CCG Fostamatinib  TAVLESSE ®
04.07.04.02 Formulary CCG Fremanezumab Ajovy®
04.07.04.02 Formulary CCG Galcanezumab  Emgality®
10.01.03 Formulary CCG Guselkumab Tremfya®
13.05.03 Formulary CCG Guselkumab Tremfya®
13.05.02 Formulary CCG Ixekizumab  Taltz®
04.05.01 Formulary CCG Liraglutide Saxenda®
09.06 Formulary CCG Paravit CF® 
07.04.03 Formulary CCG Pentosan polysulfate sodium  
06.07.02 Formulary CCG Relugolix–estradiol–norethisterone acetate Ryeqo ®
04.06 Formulary CCG Rimegepant Vydura
10.01.03 Formulary CCG Risankizumab Skyrizi®
13.05.03 Formulary CCG Risankizumab Skyrizi®
10.01.03 Formulary CCG Sarilumab Kevzara®
04.05.01 Formulary CCG Semaglutide  Wegovy®
09.02.01.01 Formulary CCG Sodium zirconium cyclosilicate Lokelma®
13.05.03 Formulary CCG Tildrakizumab Ilumetri®
13.05.03 Formulary CCG Tralokinumab Adtralza ®
10.01.03 Formulary CCG Upadacitinib  Rinvoq ®
13.05.03 Formulary CCG Upadacitinib  Rinvoq ®
Lancashire and South Cumbria